| Product Code: ETC7644794 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Alzheimers Disease Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Alzheimers Disease Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Alzheimers Disease Market - Industry Life Cycle |
3.4 Israel Alzheimers Disease Market - Porter's Five Forces |
3.5 Israel Alzheimers Disease Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Israel Alzheimers Disease Market Revenues & Volume Share, By Therapeutics, 2021 & 2031F |
3.7 Israel Alzheimers Disease Market Revenues & Volume Share, By Diagnostics, 2021 & 2031F |
3.8 Israel Alzheimers Disease Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Israel Alzheimers Disease Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 Israel Alzheimers Disease Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Israel Alzheimers Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing aging population in Israel |
4.2.2 Growing awareness and diagnosis rates of Alzheimer's disease |
4.2.3 Advancements in medical research leading to new treatment options |
4.3 Market Restraints |
4.3.1 High cost of Alzheimer's disease treatments |
4.3.2 Limited availability of specialized care facilities for Alzheimer's patients |
5 Israel Alzheimers Disease Market Trends |
6 Israel Alzheimers Disease Market, By Types |
6.1 Israel Alzheimers Disease Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Alzheimers Disease Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Israel Alzheimers Disease Market Revenues & Volume, By Early-onset Alzheimer's, 2021- 2031F |
6.1.4 Israel Alzheimers Disease Market Revenues & Volume, By Late-onset Alzheimer's, 2021- 2031F |
6.1.5 Israel Alzheimers Disease Market Revenues & Volume, By Familial Alzheimer's disease, 2021- 2031F |
6.2 Israel Alzheimers Disease Market, By Therapeutics |
6.2.1 Overview and Analysis |
6.2.2 Israel Alzheimers Disease Market Revenues & Volume, By Cholinesterase Inhibitors, 2021- 2031F |
6.2.3 Israel Alzheimers Disease Market Revenues & Volume, By NMDA Receptor Antagonists, 2021- 2031F |
6.2.4 Israel Alzheimers Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Israel Alzheimers Disease Market, By Diagnostics |
6.3.1 Overview and Analysis |
6.3.2 Israel Alzheimers Disease Market Revenues & Volume, By Magnetic Resonance Imaging, 2021- 2031F |
6.3.3 Israel Alzheimers Disease Market Revenues & Volume, By Lumbar Puncture Test, 2021- 2031F |
6.3.4 Israel Alzheimers Disease Market Revenues & Volume, By Electroencephalography, 2021- 2031F |
6.3.5 Israel Alzheimers Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Israel Alzheimers Disease Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Israel Alzheimers Disease Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 Israel Alzheimers Disease Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.4.4 Israel Alzheimers Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Israel Alzheimers Disease Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 Israel Alzheimers Disease Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Israel Alzheimers Disease Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.4 Israel Alzheimers Disease Market Revenues & Volume, By Homecare, 2021- 2031F |
6.5.5 Israel Alzheimers Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Israel Alzheimers Disease Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Israel Alzheimers Disease Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 Israel Alzheimers Disease Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 Israel Alzheimers Disease Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.6.5 Israel Alzheimers Disease Market Revenues & Volume, By Others, 2021- 2031F |
7 Israel Alzheimers Disease Market Import-Export Trade Statistics |
7.1 Israel Alzheimers Disease Market Export to Major Countries |
7.2 Israel Alzheimers Disease Market Imports from Major Countries |
8 Israel Alzheimers Disease Market Key Performance Indicators |
8.1 Number of clinical trials and research studies conducted for Alzheimer's disease in Israel |
8.2 Percentage of population aged 65 and above in Israel |
8.3 Investment in Alzheimer's disease research and development in Israel |
9 Israel Alzheimers Disease Market - Opportunity Assessment |
9.1 Israel Alzheimers Disease Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Israel Alzheimers Disease Market Opportunity Assessment, By Therapeutics, 2021 & 2031F |
9.3 Israel Alzheimers Disease Market Opportunity Assessment, By Diagnostics, 2021 & 2031F |
9.4 Israel Alzheimers Disease Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Israel Alzheimers Disease Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 Israel Alzheimers Disease Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Israel Alzheimers Disease Market - Competitive Landscape |
10.1 Israel Alzheimers Disease Market Revenue Share, By Companies, 2024 |
10.2 Israel Alzheimers Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |